Synapse - Robert Motzer

Results (123)

Phase I/II study of paclitaxel plus ifosfamide (TI) followed by high-dose paclitaxel, ifosfamide, and carboplatin (TIC) with autologous stem cell transplant (ASCT) for salvage treatment of germ cell tumors (GCT)

Meeting Abstract

Jia, X.; Feldman, D. R.; Glezerman, I.; Van Alstine, L. J.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M. S.; Reich, L.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Paclitaxel, ifosfamide, and cisplatin (TIP) efficacy for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)

Meeting Abstract

Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Targeted therapy for renal cell carcinoma (RCC) with brain metastasis: Overall survival (OS) and safety

Meeting Abstract

Bastos, D. A.; Molina, A. M.; Jia, X.; Velasco, S.; Patil, S.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Intra- and interobserver variability in CT measurements in oncology

Journal Article

McErlean, A.; Panicek, D. M.; Zabor, E. C.; Moskowitz, C. S.; Bitar, R.; Motzer, R. J.; Hricak, H.; Ginsberg, M. S.
Radiology (2013)

Fulltext@MSK | Save

Long-term response to sunitinib therapy for metastatic renal cell carcinoma

Journal Article

Molina, A. M.; Jia, X.; Feldman, D. R.; Hsieh, J. J.; Ginsberg, M. S.; Velasco, S.; Patil, S.; Motzer, R. J.
Clinical Genitourinary Cancer (2013)

Fulltext@MSK | Save

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA research network

Journal Article

Hakimi, A. A.; Ostrovnaya, I.; Reva, B.; Schultz, N.; Chen, Y. B.; Gonen, M.; Liu, H.; Takeda, S.; Voss, M. H.; Tickoo, S. K.; more...
Clinical Cancer Research (2013)

Fulltext@MSK | Save

Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older

Journal Article

Feldman, D. R.; Voss, M. H.; Jacobsen, E. P.; Jia, X.; Suarez, J. A.; Turkula, S.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.; Patil, S.
Cancer (2013)

Fulltext@MSK | Save

Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma

Journal Article

Hakimi, A. A.; Chen, Y. B.; Wren, J.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; Reuter, V. E.; more...
European Urology (2013)

Fulltext@MSK | Save

Serum tumor marker (STM) decline rates during high-dose chemotherapy (HDCT) to predict outcome for germ cell tumor (GCT) patients (pts)

Meeting Abstract

Feldman, D. R.; Voss, M. H.; Jia, X.; Van Alstine, L. J.; Patil, S.; Fischer, P.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

Tumor suppressor screens of 3p chromatin modulators link BAP1 mutations to poor clinical outcomes in clear cell renal cell carcinoma

Meeting Abstract

Hakimi, A. A.; Chen, Y. B.; Wren, J.; Ostrovnaya, I.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; more...
BJU International (2012)

Fulltext@MSK | Save